Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions

Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions

US Patent 10874730 · Granted Dec 29, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating EGFRvIII expressing glioblastomas2024
Methods of treating glioblastomas2024
H3.3 CTL peptides and uses thereof2024
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor2024
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL respon2023
H3.3 CTL peptides and uses thereof2021
H3.3 CTL peptides and uses thereof2020
Method for treating brain tumors2020
H3.3 CTL peptides and uses thereof2019
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL respon2019
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor2019
Engineered dendritic cells and uses for the treatment of cancer2017